oppn parties Will Serum Institute Profiteer By Selling To States And Private Hospitals At The Stated Rates?

News Snippets

  • Burglars cut through strong room wall and disappear with jewellery worth Rs 25cr in delhi's Bhogal area
  • Supreme Court says it will first deal with maintainability of Gyanvapi suit in light of 1991 Act
  • Fresh horror in Manipur as two Meiteis hacked in Kuki area
  • External Affairs minister S jaishankar says stance on terrorism cannot be decided by political convenience
  • Supreme Court says Centre must take active steps for transfer and appointment of HC judges otherwise it will not sit quiet
  • GST Council to meet on October 7 to discuss implementation of tax on online gaming among other things
  • 5-judge bench order saying unstamped arbitration agreement had no legal validity referred to 7-judge bench by Supreme Court
  • Centre to issue 50-year security, green bonds
  • Government announces 5 new ways to calculate angel tax on selling of stake in unlisted companies
  • Stock markets end flat on Tuesday with negative bais: Sensex sheds 78 points to 65945 and Nifty 9 points to 19664
  • Asian Games: India beat Singapore 16-1 in hockey but miss many penalty corners
  • India suffers from reduced strength as some players are rested and others are down with viral fever as they take on Australia in the 3rd and final ODI
  • Asian Games: Equestrian gold and silver in sailing as Indians do well
  • PM Modi flags off 9 Vande Bharat trains across 11 states
  • Odisha chief minister Naveen Patnaik says he would rate PM Modi 8 out of 10 on foriegn policy and various other parameters
Sift Kaur Samra smashes world record to win gold in 50m rifle 3 position /////// Indian equestrian team wins gold in dressage event
oppn parties
Will Serum Institute Profiteer By Selling To States And Private Hospitals At The Stated Rates?

By Sunil Garodia
First publised on 2021-04-24 03:34:51

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator.

Indian Express has reported that Serum Institute is going to sell the Covishield vaccine (developed by Oxford University and AstraZeneca and being contract-manufactured in India by Serum) to private hospitals in India at the world's highest rate. It has made a rate chart (see lead picture) which shows that while the vaccine is available all over the world at between $ 2.15 (Rs. 162 in the European Union) to $5.25 (Rs. 395 in South Africa and Saudi Arabia). Serum has said that it will sell at Rs. 400 per dose to state governments and at Rs. 600 per dose to private hospitals. Although it had sold the first 100 million doses to the Central government at Rs. 150 per dose, Adar Poonawala, the CEO of Serum had stated at that time that the final price for private markets would be Rs.1000 per dose. Yet, the company had said that it was making a small profit even while selling to the Centre at Rs. 150 per dose.

So is Poonawala not the angel he first seemed when his company took a calculated gamble and produced the vaccine "at-risk" even before it was approved and supplied the shots immediately when they were approved at probably the cheapest rate in the world? Should he and Serum be allowed to get away with making huge profits by now supplying the shots at prices much higher than other countries pay, especially when the Centre has ploughed in Rs 3000 crore as advance payment for it to ramp up production? This is interest-free tax payers money Serum is getting and it should keep this in mind before fixing the rates for the shots.

India is a huge market. If Covishield can be supplied between Rs 162 and Rs 300 per dose in the European Union and UK, one feels that anything between that should be the rate at which Serum should supply to both the Centre and the states. It can charge a little extra for private hospitals. Ideally, the Centre should negotiate a combined rate for itself and the states and it should not be more than Rs. 250 per dose. Serum can then price the doses at Rs. 300 for private hospitals. Making profits is the right of all commercial entities and Serum should be allowed to make reasonable profits for its enterprise. But profiteering cannot be tolerated, not even in normal times let alone in a pandemic.